| 000 | 01009 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250511201148.0 | ||
| 264 | 0 | _c19901102 | |
| 008 | 199011s 0 0 fre d | ||
| 022 | _a0007-4551 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAzab, M | |
| 245 | 0 | 0 |
_a[II International congress on the strategy of symptomatic treatment in oncology]. _h[electronic resource] |
| 260 |
_bBulletin du cancer _c1990 |
||
| 300 |
_a799-804 p. _bdigital |
||
| 500 | _aPublication Type: Congress | ||
| 650 | 0 | 4 |
_aAntiemetics _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aBiological Factors _xphysiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInfections _xdrug therapy |
| 650 | 0 | 4 |
_aMetabolic Diseases _xetiology |
| 650 | 0 | 4 |
_aNeoplasms _xcomplications |
| 650 | 0 | 4 |
_aNeutropenia _xcomplications |
| 650 | 0 | 4 |
_aPain, Intractable _xdrug therapy |
| 650 | 0 | 4 | _aPalliative Care |
| 650 | 0 | 4 |
_aVomiting _xdrug therapy |
| 773 | 0 |
_tBulletin du cancer _gvol. 77 _gno. 8 _gp. 799-804 |
|
| 999 |
_c1704890 _d1704890 |
||